Applied Genetic Technologies reported $16.42M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Applied Genetic Technologies AGTC:US $ 16.42M 2.14M
Avrobio Inc AVRO:US 32.62M 1.24M
Biogen BIIB:US $ 1984.9M 304.4M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Celldex Therapeutics CLDX:US $ 20.98M 4.06M
Cti Biopharma CTIC:US $ 23.38M 3.88M
Gilead Sciences GILD:US $ 3579M 392M
Insmed INSM:US $ 150.37M 1.25M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
Life Technologies LIFE:US $ 7.73M 2.72M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Rigel Pharmaceuticals RIGL:US $ 41.33M 2.01M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M